Piper Sandler Adjusts Edap TMS Rating and Target Price

Summary

Piper Sandler maintained Edap TMS’s rating at ‘Overweight’ but adjusted the target price from $5.00 to $4.50. Edap TMS SA is a holding company with divisions in HIFU, ESWL, and distribution, focusing on high-intensity focused ultrasound technology and extracorporeal shock wave lithotripsy equipment, with operations in Asia, France, and the USA.Stock Star

Impact Analysis

The event is at the company level, focusing on Edap TMS. Piper Sandler’s rating adjustment reflects a slightly less optimistic outlook, possibly due to financial performance or market conditions. The reduction in target price may prompt negative investor sentiment, affecting short-term stock performance. However, HC Wainwright maintained a ‘Buy’ rating with a higher target price of $19.00, indicating differing analyst opinions.Market Beat Despite a reduction in adjusted loss per share, Edap TMS’s financials suggest mixed signals.Reuters The company has net cash, reducing debt concerns.Simplywall Overall, the event presents both risks and opportunities. Investors should consider analyst diversity, recent financial performance, and the company’s strategic market entry to gauge future stock movements.